Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-19-001529)

Filing Details

Accession Number:: 0001562180-19-001529
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-01 16:46:00
Reporting Period:: 2019-03-01

Accepted Time:: 2019-03-01 16:46:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597553	Sage Therapeutics Inc.	SAGE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304815	Kimi Iguchi	C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142	Cfo & Treasurer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-03-01	25,563	$156.93	1,413	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Reflects the amount of securities beneficially owned by the reporting person which includes 150 shares acquired by the reporting person pursuant to the issuer's employee stock purchase plan in June 2018.